Acadian Asset Management
CNTA

Acadian Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Acadian Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,496
Closed -$211K – 2054
2025
Q4 		$211K Buy
+8,496
New +$215K ﹤0.01% 1514
2025
Q1 		– Sell
-1,457
Closed -$24K – 1647
2024
Q4 		$24K Buy
+1,457
New +$24.1K ﹤0.01% 1531
2024
Q2 		– Sell
-29,409
Closed -$330K – 1768
2024
Q1 		$330K Buy
+29,409
New +$278K ﹤0.01% 1092

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Acadian Asset Management's CNTA Position: Q1 2026 in Review

Acadian Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 8,496 shares — an estimated $211K sold.

Acadian Asset Management first reported a position in CNTA in Q1 2024 and held it in 3 quarters. The position peaked at $330K in Q1 2024. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Acadian Asset Management reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 8,496 Centessa Pharmaceuticals shares in Q1 2026, an estimated $211K.
  • Acadian Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Acadian Asset Management's Centessa Pharmaceuticals position peaked at $330K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.